Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.

Shi L, Westwood S, Baird AL, Winchester L, Dobricic V, Kilpert F, Hong S, Franke A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Buckley NJ, Kate MT, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Zetterberg H, Baker S, Morgan BP, Streffer J, Visser PJ, Bertram L, Lovestone S, Nevado-Holgado AJ.

Alzheimers Dement. 2019 Sep 5. pii: S1552-5260(19)35118-0. doi: 10.1016/j.jalz.2019.06.4951. [Epub ahead of print]

2.

miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.

Ansari A, Maffioletti E, Milanesi E, Marizzoni M, Frisoni GB, Blin O, Richardson JC, Bordet R, Forloni G, Gennarelli M, Bocchio-Chiavetto L; PharmaCog Consortium.

Neurobiol Aging. 2019 Jun 21;82:102-109. doi: 10.1016/j.neurobiolaging.2019.06.005. [Epub ahead of print]

PMID:
31437718
3.

Sleep deprivation and Modafinil affect cortical sources of resting state electroencephalographic rhythms in healthy young adults.

Del Percio C, Derambure P, Noce G, Lizio R, Bartrés-Faz D, Blin O, Payoux P, Deplanque D, Méligne D, Chauveau N, Bourriez JL, Casse-Perrot C, Lanteaume L, Thalamas C, Dukart J, Ferri R, Pascarelli MT, Richardson JC, Bordet R, Babiloni C; PharmaCog Consortium.

Clin Neurophysiol. 2019 Sep;130(9):1488-1498. doi: 10.1016/j.clinph.2019.06.007. Epub 2019 Jul 1.

PMID:
31295717
4.

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.

Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, Ten Kate M, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey F, Sala I, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Barkhof F, Ashton N, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C.

Alzheimers Dement. 2019 Jun;15(6):817-827. doi: 10.1016/j.jalz.2019.03.004. Epub 2019 May 8.

5.

Inflammatory biomarkers in Alzheimer's disease plasma.

Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ; NIMA Consortium, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, Johannsen P, Kettunen P, Kłoszewska I, Legido-Quigley C, Lleó A, Martinez-Lage P, Mecocci P, Meersmans K, Molinuevo JL, Peyratout G, Popp J, Richardson J, Sala I, Scheltens P, Streffer J, Soininen H, Tainta-Cuezva M, Teunissen C, Tsolaki M, Vandenberghe R, Visser PJ, Vos S, Wahlund LO, Wallin A, Westwood S, Zetterberg H, Lovestone S, Morgan BP; Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease.

Alzheimers Dement. 2019 Jun;15(6):776-787. doi: 10.1016/j.jalz.2019.03.007. Epub 2019 Apr 30.

6.

Staphylococcus aureus nasal decolonization strategies: a review.

Sakr A, Brégeon F, Rolain JM, Blin O.

Expert Rev Anti Infect Ther. 2019 May;17(5):327-340. doi: 10.1080/14787210.2019.1604220. Epub 2019 Apr 23.

PMID:
31012332
7.

One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI).

Frisoni GB, Blin O, Bordet R.

J Alzheimers Dis. 2019;69(1):1-2. doi: 10.3233/JAD-190267. No abstract available.

PMID:
30958385
8.

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.

Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):49-58. doi: 10.3233/JAD-181016.

PMID:
30958351
9.

Quantitative System Pharmacology (QSP): An Integrative Framework for paradigm change in the treatment of the first-episode schizophrenia.

Gaillard-Bigot F, Zendjidjian XY, Kheloufi F, Casse-Perrot C, Guilhaumou R, Micallef J, Fakra E, Azorin JM, Blin O.

Encephale. 2018 Dec;44(6S):S34-S38. doi: 10.1016/S0013-7006(19)30077-6. French.

PMID:
30935485
10.

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.

Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ.

Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.

PMID:
30853464
11.

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoniand GB; and the PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):15-35. doi: 10.3233/JAD-180158.

PMID:
30400088
12.

Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections.

Sakr A, Brégeon F, Mège JL, Rolain JM, Blin O.

Front Microbiol. 2018 Oct 8;9:2419. doi: 10.3389/fmicb.2018.02419. eCollection 2018. Review.

13.

Prolonged continuous wound infiltration with a local anaesthetic after total mastectomy: pharmacokinetics and preliminary results on postoperative pain.

Francon D, Riff C, Blin O, Cohen M, Guilhaumou R.

Anaesth Crit Care Pain Med. 2019 Aug;38(4):385-386. doi: 10.1016/j.accpm.2018.08.002. Epub 2018 Oct 4. No abstract available.

PMID:
30292487
14.

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.

Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, Engelborghs S, Van Broeckhoven C, Martinez-Lage P, Popp J, Tsolaki M, Verhey FRJ, Baird AL, Legido-Quigley C, Bertram L, Dobricic V, Zetterberg H, Lovestone S, Streffer J, Bianchetti S, Novak GP, Revillard J, Gordon MF, Xie Z, Wottschel V, Frisoni G, Visser PJ, Barkhof F.

Alzheimers Res Ther. 2018 Sep 27;10(1):100. doi: 10.1186/s13195-018-0428-1.

15.

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.

Albani D, Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):37-48. doi: 10.3233/JAD-180321.

PMID:
30149449
16.

Adaptability and reproducibility of a memory disruption rTMS protocol in the PharmaCog IMI European project.

Martin-Trias P, Lanteaume L, Solana E, Cassé-Perrot C, Fernández-Cabello S, Babiloni C, Marzano N, Junqué C, Rossini PM, Micallef J, Truillet R, Charles E, Jouve E, Bordet R, Santamaria J, Jovicich J, Rossi S, Pascual-Leone A, Blin O, Richardson J, Bartrés-Faz D.

Sci Rep. 2018 Jun 19;8(1):9371. doi: 10.1038/s41598-018-27502-1.

17.

Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.

Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Salvatore M, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):3-14. doi: 10.3233/JAD-180152.

PMID:
29914031
18.

Population pharmacokinetic model for tumescent lidocaine in women undergoing breast cancer surgery.

Riff C, Bourgoin A, Marsot A, Allanioux L, Leone M, Blin O, Guilhaumou R.

Eur J Clin Pharmacol. 2018 Oct;74(10):1309-1315. doi: 10.1007/s00228-018-2503-8. Epub 2018 Jun 16.

PMID:
29909577
19.

Tumescent local anaesthesia for breast cancer surgery in elderly women: about 6 cases.

Riff C, Diaz A, Blin O, Leone M, Guilhaumou R, Bourgoin A.

Anaesth Crit Care Pain Med. 2019 Aug;38(4):387-389. doi: 10.1016/j.accpm.2018.05.008. Epub 2018 Jun 1. No abstract available.

PMID:
29864551
20.

Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double-blind, placebo-controlled, crossover trial.

Micallef J, Dupouey J, Jouve E, Truillet R, Lacarelle B, Taillard J, Daurat A, Authié C, Blin O, Rascol O, Philip P, Mestre D.

Fundam Clin Pharmacol. 2018 Oct;32(5):558-570. doi: 10.1111/fcp.12382. Epub 2018 Jun 6.

PMID:
29752828
21.

Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.

Marsot A, Gallais F, Galambrun C, Coze C, Blin O, Andre N, Guilhaumou R.

Paediatr Drugs. 2018 Aug;20(4):375-381. doi: 10.1007/s40272-018-0295-z.

PMID:
29736878
22.

Ropivacaine Wound Infiltration for Pain Management After Breast Cancer Mastectomy: A Population Pharmacokinetic Analysis.

Riff C, Guilhaumou R, Marsot A, Beaussier M, Cohen M, Blin O, Francon D.

Clin Pharmacol Drug Dev. 2018 Nov;7(8):811-819. doi: 10.1002/cpdd.452. Epub 2018 Apr 16.

PMID:
29659182
23.

Effect of desipramine on patients with breathing disorders in RETT syndrome.

Mancini J, Dubus JC, Jouve E, Roux JC, Franco P, Lagrue E, Castelnau P, Cances C, Chaix Y, Rougeot-Jung C, Cornu C, Desportes V, Vallée L, Bahi-Buisson N, Truillet R, Attolini L, Villard L, Blin O, Micallef J.

Ann Clin Transl Neurol. 2017 Dec 27;5(2):118-127. doi: 10.1002/acn3.468. eCollection 2018 Feb.

24.

Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation.

Wirsich J, Rey M, Guye M, Bénar C, Lanteaume L, Ridley B, Confort-Gouny S, Cassé-Perrot C, Soulier E, Viout P, Rouby F, Lefebvre MN, Audebert C, Truillet R, Jouve E, Payoux P, Bartrés-Faz D, Bordet R, Richardson JC, Babiloni C, Rossini PM, Micallef J, Blin O, Ranjeva JP; Pharmacog Consortium.

Brain Topogr. 2018 May;31(3):380-391. doi: 10.1007/s10548-017-0608-5. Epub 2017 Nov 23.

PMID:
29170853
25.

Perampanel-associated self-harm ideation after dosage increase.

Kheloufi F, Default A, Perrouty B, Blin O, Micallef J.

Eur J Clin Pharmacol. 2018 Feb;74(2):243-244. doi: 10.1007/s00228-017-2348-6. Epub 2017 Nov 11. No abstract available.

PMID:
29128971
26.

Impaired cortico-limbic functional connectivity in schizophrenia patients during emotion processing.

Comte M, Zendjidjian XY, Coull JT, Cancel A, Boutet C, Schneider FC, Sage T, Lazerges PE, Jaafari N, Ibrahim EC, Azorin JM, Blin O, Fakra E.

Soc Cogn Affect Neurosci. 2017 Oct 23. doi: 10.1093/scan/nsx083. [Epub ahead of print]

27.

Modeling a linkage between blood transcriptional expression and activity in brain regions to infer the phenotype of schizophrenia patients.

Ibrahim EC, Guillemot V, Comte M, Tenenhaus A, Zendjidjian XY, Cancel A, Belzeaux R, Sauvanaud F, Blin O, Frouin V, Fakra E.

NPJ Schizophr. 2017 Sep 7;3(1):25. doi: 10.1038/s41537-017-0027-3.

28.

Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology.

Micallef J, Boutouyrie P, Blin O.

Fundam Clin Pharmacol. 2017 Dec;31(6):685-694. doi: 10.1111/fcp.12314. Epub 2017 Aug 24.

PMID:
28779530
29.

Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis.

Marsot A, Guilhaumou R, Azulay JP, Blin O.

J Pharm Pharm Sci. 2017;20(0):226-238. doi: 10.18433/J30H04. Review.

30.

Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect.

Kheloufi F, Boucherie Q, Blin O, Micallef J.

AIDS. 2017 Jul 31;31(12):1775-1777. doi: 10.1097/QAD.0000000000001557. No abstract available.

PMID:
28700395
31.

Comment on "Patient Reporting in the EU: Analysis of EudraVigilance Data".

Kheloufi F, Default A, Rouby F, Blin O, Micallef J.

Drug Saf. 2017 Oct;40(10):935-936. doi: 10.1007/s40264-017-0568-4. No abstract available.

PMID:
28676981
32.

Analytical interference during cefepime therapeutic drug monitoring in intensive care patient: About a case report.

Toullec L, Dupouey J, Vigne C, Marsot A, Allanioux L, Blin O, Leone M, Guilhaumou R.

Therapie. 2017 Oct;72(5):587-592. doi: 10.1016/j.therap.2017.02.003. Epub 2017 Mar 30.

PMID:
28457572
33.

Phenobarbital in intensive care unit pediatric population: predictive performances of population pharmacokinetic model.

Marsot A, Michel F, Chasseloup E, Paut O, Guilhaumou R, Blin O.

Fundam Clin Pharmacol. 2017 Oct;31(5):558-566. doi: 10.1111/fcp.12291. Epub 2017 May 24.

PMID:
28407406
34.

Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?

Kheloufi F, Default A, Rouby F, Laugier-Castellan D, Boyer M, Rodrigues B, Ponte-Astoul J, Jean-Pastor MJ, Blin O, Micallef J.

Eur J Clin Pharmacol. 2017 Aug;73(8):1009-1018. doi: 10.1007/s00228-017-2254-y. Epub 2017 Apr 8.

PMID:
28391408
35.

[What role for paraclinical investigations within clinical trials conducted in psychiatric patients?]

Kaladjian A, Adida M, Simon N, Belzeaux R, Blin O, Fakra E, Azorin JM.

Encephale. 2016 Dec;42(6S):S47-S50. doi: 10.1016/S0013-7006(17)30054-4. French.

PMID:
28236993
36.

[Evaluating the efficacy of long acting injectable antipsychotics through clinical trials].

Fakra E, Azorin JM, Belzeaux R, Adida M, Blin O, Kaladjian A.

Encephale. 2016 Dec;42(6S):S43-S46. doi: 10.1016/S0013-7006(17)30053-2. French.

PMID:
28236992
37.

[How may practitioners interpret the results of clinical trials?]

Azorin JM, Adida M, Blin O, Simon N, Fakra E, Cermolacce M, Bottai T, Pringuey D, Micoulaud-Franchi JA, Belzeaux R, Kaladjian A.

Encephale. 2016 Dec;42(6S):S26-S29. doi: 10.1016/S0013-7006(17)30050-7. French.

PMID:
28236989
38.

[What can we expect from clinical trials in psychiatry?]

Marsot A, Boucherie Q, Kheloufi F, Riff C, Braunstein D, Dupouey J, Guilhaumou R, Zendjidjian X, Bonin-Guillaume S, Fakra E, Guye M, Jirsa V, Azorin JM, Belzeaux R, Adida M, Micallef J, Blin O.

Encephale. 2016 Dec;42(6S):S2-S6. doi: 10.1016/S0013-7006(17)30046-5. French.

PMID:
28236988
39.

Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).

Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Müller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Payoux P, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

Neurobiol Aging. 2017 May;53:1-10. doi: 10.1016/j.neurobiolaging.2017.01.013. Epub 2017 Jan 18.

PMID:
28189924
40.

Population pharmacokinetics model of THC used by pulmonary route in occasional cannabis smokers.

Marsot A, Audebert C, Attolini L, Lacarelle B, Micallef J, Blin O.

J Pharmacol Toxicol Methods. 2017 May - Jun;85:49-54. doi: 10.1016/j.vascn.2017.02.003. Epub 2017 Feb 4.

PMID:
28167229
41.

A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients.

Wang W, Guedj M, Bertrand V, Foucquier J, Jouve E, Commenges D, Proust-Lima C, Murphy NP, Blin O, Magy L, Cohen D, Attarian S.

PLoS One. 2017 Jan 17;12(1):e0169878. doi: 10.1371/journal.pone.0169878. eCollection 2017.

42.

Investigating patient narratives posted on Internet and their informativeness level for pharmacovigilance purpose: The example of comments about statins.

Kheloufi F, Default A, Blin O, Micallef J.

Therapie. 2017 Sep;72(4):483-490. doi: 10.1016/j.therap.2016.10.004. Epub 2016 Dec 9.

PMID:
28065444
43.

Childhood trauma and emotional processing circuits in schizophrenia: A functional connectivity study.

Cancel A, Comte M, Boutet C, Schneider FC, Rousseau PF, Boukezzi S, Gay A, Sigaud T, Massoubre C, Berna F, Zendjidjian XY, Azorin JM, Blin O, Fakra E.

Schizophr Res. 2017 Jun;184:69-72. doi: 10.1016/j.schres.2016.12.003. Epub 2016 Dec 13.

PMID:
27979699
44.

Antidepressant adherence patterns in older patients: use of a clustering method on a prescription database.

Braunstein D, Hardy A, Boucherie Q, Frauger E, Blin O, Gentile G, Micallef J.

Fundam Clin Pharmacol. 2017 Apr;31(2):226-236. doi: 10.1111/fcp.12252. Epub 2017 Jan 10.

PMID:
27862243
45.

Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.

Marsot A, Ménard A, Dupouey J, Muziotti C, Guilhaumou R, Blin O.

Br J Clin Pharmacol. 2017 May;83(5):1039-1047. doi: 10.1111/bcp.13178. Epub 2017 Jan 16.

46.

Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette.

Marsot A, Audebert C, Attolini L, Lacarelle B, Micallef J, Blin O.

J Pharm Pharm Sci. 2016 Jul - Sep;19(3):411-422. doi: 10.18433/J3F31D.

47.

Long-term use of antipsychotics in community-dwelling dementia patients: prevalence and profile accounting for unobservable time bias because of hospitalization.

Boucherie Q, Gentile G, Chalançon C, Sciortino V, Blin O, Micallef J, Bonin-Guillaume S.

Int Clin Psychopharmacol. 2017 Jan;32(1):13-19.

PMID:
27741029
48.

Conclusive Article: Sorting the Good from the Bad: The Different Approaches to Predict Cognitive Properties of New Symptomatic Drug Candidates for Neurodegenerative Diseases in Early Development.

Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Herrero MT, Blin O, Micallef J, Richardson JC, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):837-8. Review. No abstract available.

PMID:
27549168
49.

Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle.

Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Blin O, Micallef J, Richardson JC, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):754-5. Review. No abstract available.

PMID:
27549167
50.

Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects.

Albi A, Pasternak O, Minati L, Marizzoni M, Bartrés-Faz D, Bargalló N, Bosch B, Rossini PM, Marra C, Müller B, Fiedler U, Wiltfang J, Roccatagliata L, Picco A, Nobili FM, Blin O, Sein J, Ranjeva JP, Didic M, Bombois S, Lopes R, Bordet R, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Frisoni G, Jovicich J; PharmaCog Consortium.

Hum Brain Mapp. 2017 Jan;38(1):12-26. doi: 10.1002/hbm.23350. Epub 2016 Aug 13.

Supplemental Content

Support Center